We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.89B
AUM Growth
-$1.49B
(-14%)
Cap. Flow
-$1.55B
Cap. Flow
% of AUM
-17.42%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$37.3M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$31.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$27.8M |
| 4 |
Newmont
NEM
|
+$27.4M |
| 5 |
Cummins
CMI
|
+$24.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$430M |
| 2 |
JPMorgan Chase
JPM
|
+$168M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$132M |
| 4 |
Yum! Brands
YUM
|
+$105M |
| 5 |
Pfizer
PFE
|
+$92.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 59.33% |
| 2 | Technology | 6.01% |
| 3 | Healthcare | 4.63% |
| 4 | Consumer Discretionary | 3.72% |
| 5 | Financials | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Tonix Pharmaceuticals
TNXP
$157M
| $196K | ﹤0.01% |
+1
| New | +$318K |
|
|
CTRA
877
DELISTED
Coterra Energy
CTRA
| $194K | ﹤0.01% |
10,217
-1,941
| -16% | -$40.5K |
|
|
AVEO
878
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $187K | ﹤0.01% |
39,775
-2,349
| -6% | -$14.6K |
|
879
American Vanguard Corp
AVD
$73.5M
| $174K | ﹤0.01% |
+10,629
| New | +$167K |
|
880
SunCoke Energy
SXC
$757M
| $166K | ﹤0.01% |
+25,162
| New | +$167K |
|
881
First Commonwealth Financial
FCF
$2.12B
| $165K | ﹤0.01% |
10,239
-13,886
| -58% | -$211K |
|
882
Hope Bancorp
HOPE
$1.72B
| $160K | ﹤0.01% |
10,859
-9,605
| -47% | -$142K |
|
883
Archrock
AROC
$6.33B
| $158K | ﹤0.01% |
+21,092
| New | +$170K |
|
884
Kearny Financial
KRNY
$592M
| $158K | ﹤0.01% |
11,955
-12,635
| -51% | -$166K |
|
885
GrafTech
EAF
$194M
| $156K | ﹤0.01% |
+1,320
| New | +$153K |
|
886
Acco Brands
ACCO
$369M
| $155K | ﹤0.01% |
+18,818
| New | +$162K |
|
887
CoreCivic
CXW
$3.1B
| $147K | ﹤0.01% |
14,740
-20,449
| -58% | -$203K |
|
888
NGL Energy Partners
NGL
$1.94B
| $112K | ﹤0.01% |
61,390
+7,696
| +14% | +$17.2K |
|
889
AC Immune
ACIU
$227M
| – | – |
-89,040
| Closed | -$597K |
|
|
ADAP
890
DELISTED
Adaptimmune Therapeutics
ADAP
| – | – |
-190,550
| Closed | -$985K |
|
|
ADVM
891
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-12,027
| Closed | -$261K |
|
892
Ameriprise Financial
AMP
$46.8B
| – | – |
-8,307
| Closed | -$2.19M |
|
|
APLS
893
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-106,632
| Closed | -$3.52M |
|
|
CVSA
894
Covista Inc
CVSA
$3.94B
| – | – |
-6,105
| Closed | -$231K |
|
895
Aurinia Pharmaceuticals
AUPH
$1.97B
| – | – |
-157,076
| Closed | -$3.48M |
|
896
Credicorp
BAP
$30.9B
| – | – |
-5,020
| Closed | -$557K |
|
897
Beam Global
BEEM
$22.4M
| – | – |
-75,856
| Closed | -$2.08M |
|
898
Brown-Forman Class A
BF.A
$12.3B
| – | – |
-4,692
| Closed | -$294K |
|
|
BFS
899
Saul Centers
BFS
$875M
| – | – |
-16,407
| Closed | -$723K |
|
900
B&G Foods
BGS
$285M
| – | – |
-330,000
| Closed | -$9.86M |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, ALPS Advisors held 1,012 positions worth $8.89B, down 14% from $10.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ALPS Advisors withdrew a net $1.55B in Q4 2021, closing 124 positions and reducing 302 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $430M position sold in full.
By sector, the portfolio is most concentrated in Energy at 59% of assets, up from 51% a quarter earlier, followed by Technology and Healthcare.
Against the trend, ALPS Advisors opened a new position in Bristol-Myers Squibb worth $29.6M.
- ALPS Advisors's largest Q4 2021 buy was Bristol-Myers Squibb: 474,459 shares worth $29.6M.
- ALPS Advisors added most to Energy Transfer Partners in Q4 2021, an estimated $37.3M increase.
- ALPS Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $168M.
- ALPS Advisors fully exited Berkshire Hathaway Class A in Q4 2021, selling an estimated $430M.
- ALPS Advisors's ten largest holdings make up 48% of its $8.89B portfolio in Q4 2021.
- ALPS Advisors opened 106 new positions and closed 124 in Q4 2021.
- ALPS Advisors's portfolio value fell 14% quarter-over-quarter to $8.89B.
Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.